Yogurt Containing the Probacteria Lactobacillus acidophilus Combined with Natural Antioxidants Mitigates Doxorubicin-Induced Cardiomyopathy in Rats

Journal of Medicinal Food

Volumn 18, Issue 9, 2015, Pages 950-959

  Abu Elsaad, Nashwa M ^a   Abd Elhameed, Ahmed G ^a   El Karef, Amr ^b   Ibrahim, Tarek M ^a  

^a University of Mansoura   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

cardiomyopathy; doxorubicin; functional food; IL; probiotics; TNF

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOTENSIN II; ANTIOXIDANT; ATRIAL NATRIURETIC FACTOR; CARVEDILOL; CREATINE KINASE; CREATININE; DOXORUBICIN; GLUTATHIONE; GREEN TEA EXTRACT; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; POTASSIUM; PROBIOTIC AGENT; SODIUM; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; YOGHURT; CARBAZOLE DERIVATIVE; CARDIOTONIC AGENT; CHOLESTEROL; CYTOKINE; PROPANOLAMINE DERIVATIVE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CARROT; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIET; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG EFFECT; ELECTROCARDIOGRAPH; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FUNCTIONAL FOOD; HEART EDEMA; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART RATE; HEART WEIGHT; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LACTOBACILLUS ACIDOPHILUS; LIPID PEROXIDATION; MALE; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; Q WAVE; QT INTERVAL; QT PROLONGATION; RAT; SODIUM BLOOD LEVEL; T WAVE; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; BLOOD; CAMELLIA SINENSIS; CARDIAC MUSCLE; CARDIOMYOPATHIES; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; HEART; METABOLISM; MICROBIOLOGY; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; ATRIAL NATRIURETIC FACTOR; CAMELLIA SINENSIS; CARBAZOLES; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; CHOLESTEROL; CYTOKINES; DAUCUS CAROTA; DOXORUBICIN; FUNCTIONAL FOOD; HEART; LACTOBACILLUS ACIDOPHILUS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MYOCARDIUM; OXIDATIVE STRESS; PROBIOTICS; PROPANOLAMINES; RATS, SPRAGUE-DAWLEY; YOGURT;

EID: 84941350764     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.0104     Document Type: Article

References (31)

1. Kemp CD, Conte JV: The pathophysiology of heart failure. Cardiovasc Pathol 2012;21:365-371.
2. Schwinger RHG: Pathophysiology of heart failure. Clin Res Cardiol Suppl 2010;5:16-20.
3. Francis GS: Pathophysiology of chronic heart failure. Am J Med 2001;110:37-46.
4. Matsushima S, Kinugawa S, Ide T, et al.: Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Am J Physiol Heart Circ Physiol 2006;291:H2237-H2245.
5. Tsutsui H, Kinugawa S, Matsushima S: Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 2011;301:H2181-H2190.
6. Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S: Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des 2004;10:1699-1711.
7. DiRienzo DB: Effect of probiotics on biomarkers of cardiovascular disease: Implications for heart-healthy diets. Nutr Rev 2014;72:18-29.
8. Ochmanski W, Barabasz W: Probiotics and their therapeutic properties. Przegl Lek 1999;56:211-215.
9. Kopp-Hoolihan L: Prophylactic and therapeutic uses of probiotics: A review. J Am Diet Assoc 2001;101:229-241.
10. Lou H, Danelisen I, Singal PK: Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure. J Mol Cell Cardiol 2004;36:683-690.
11. James J, Bosch KS, Aronson DC, Houtkooper JM: Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver. Liver 1990;10:1-5.
12. Moron MS, Depierre JW, Mannervik B: Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78.
13. Logeart D, Thabut G, Jourdain P, et al.: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J Am Coll Cardiol 2004;18:635-641.
14. Xu X, Persson HL, Richardson DR: Molecular pharmacology of the interaction of anthracyclines with iron. Mol Pharmacol 2005;68:261-271.
15. Lin M, Yen C: Inhibition of lipid peroxidation by Lactobacillus acidophilus and Bifidobacterium longum. J Agric Food Chem 1999;47:3661-3664.
16. Siveski-Iliskovic N, Kaul N, Singal PK: Probucol promote endogenous antioxidants and provides protection against adriamycininduced cardiomyopathy in rats. Circulation 1994;89:2829-2835.
17. Horenstein MS, Heide RSV, L'Ecuyer TJ: Molecular basis of anthracycline-induced cardiotoxicity and its prevention. Mol Genet Metab 2000;72:436-444.
18. Koutinos G, Stathopoulos GP, Dontas I, et al.: The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: An experimental study. Anticancer Res 2002;22:815-820.
19. Sugiyamaa T, Sadzuka Y: Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett 2004;212:177-184.
20. Lutgendorff F, Nijmeijer RM, Sandström PA, et al.: Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis. PLoS One 2009;4:e4512.
21. Mihm MJ, Yu F, Weinstein DM, Reiser PJ, Bauer JA: Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: Evidence for selective impairment of myofibrillar creatine kinase. Br J Pharmacol 2002;135:581-588.
22. Šimunek T, Štirba M, Popelova O, Adamcova M, Hrdina R, Geršl V: Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 2009;61:154-171.
23. Torre-Amione G, Sestier F, Radovancevic B, Young J: Broad modulation of tissue responses (immune activation) by celacade may favorably influence pathologic processes associated with heart failure progression. Am J Cardiol 2005;95:30C-37C; discussion 38C-40C.
24. Li Y, Takemura G, Okada H, Miyata S, Maruyama R: Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 2006;71:684-694.
25. Aluise CD, Miriyala S, Noel T, et al.: 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-A release: Implications for the reactive oxygen speciesmediated mechanisms of chemobrain. Free Radic Biol Med 2011;50:1630-1638.
26. Flesch M, Hoper A, Dell'Italia L, et al.: Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2003;108:598-604.
27. Goldhaber JI, Kim KH, Natterson PD, Lawrence T, Yang P, Weiss JN: Effects of TNF-alpha on [Ca2 + ] i and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol 1996;271:H1449-H1455.
28. Haudek SB, Taffet GE, Schneider MD, Mann DL: TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 2007;117:2692-2701.
29. Siwik DA, Colucci WS: Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 2004;9:43-51.
30. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S: Probiotics: Effects on immunity. Am J Clin Nutr 2001;73:444S-450S.
31. Bai AP, Ouyang Q, Xiao XR, Li SF: Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Int J Clin Pract 2006;60:284-288.